What differentiates SGAs from FGAs?

  1. The term atypical antipsychotic was first introduced in the 1990s to describe a new class of drugs that were not typical or conventional antipsychotics. These AAPs are characterized by their unique pharmacological profile, which includes low propensity for extrapyramidal side effects and high affinity for 5-HT2 receptors. They also have other distinct features such as lack of sedation, weight gain, prolactin elevation, and anticholinergic activity. The most widely used SGA is risperidone, while olanzapine and quetiapine are two newer agents approved for use in schizophrenia. In addition, clozapine remains an important treatment option for patients with refractory schizophrenia who do not respond adequately to any available medication.

SGAs has “atypical” clinical properties

  1. What differentiates SGAs from FGAs?

SGAs has “atypical” clinical properties

  1. What differentiates SGAs from FGAs?

SGAs has “atypical” clinical properties

  1. What differentiates SGAs from FGAs?

SGAs has “atypical” clinical properties

Get a 10 % discount on an order above $ 100
Use the following coupon code :
ACE16